Remote patient monitoring (RPM) technology enables a constant relationship between caregivers and patients, increases the reach of physicians, and offers providers a continuous stream of real-time health data.
Source: Market Research
According to one report by IHS (Information Handling Services), more than four million patients will monitor their health conditions remotely by 2020. This is a 34% increase in remote patient monitoring, thanks to many advancements in technology since 2014.
In this piece, we will be looking at the top five remote patient monitoring (RPM) devices to watch out for in 2020.
1) AI-Powered Wearables
AI- powered remote patient monitoring wearables help monitor, manage and engage patients at home in order to reduce cost, risk, and readmissions while increasing revenue and improving outcomes.
For high-risk patients, these devices uniquely offer continuous, wireless core vitals monitoring via the most advanced wearable available. This provides far earlier opportunities to intervene than any other RPM platform available.
Scottish startup Current Health has recently built a wearable armband with the hardware and software that provides real-time insights into a patient’s health. Its algorithms continuously analyze a number of vital signs, including pulse rate, oxygen saturation, respiration rate, temperature, and movement, from its own device, but the platform can also capture additional metrics.
The wearable developed by Current Health also deeply integrates with a patient’s electronic medical record HL7 or FHIR, while also offering advanced reporting.
AI-powered wearables are definitely set to become RPM devices to watch out for this year since they work effectively across tracking of multiple conditions such as pre and post surgery, total joint replacement, COPD, Diabetes, Oncology and heart failure.
Related: 5 Steps for Successful Implementation of Healthcare IoT
2) Microsampling Devices
Microsampling devices can economically and effortlessly collect, retrieve, transport, and analyze biological fluid samples to generate quantitative and dependable bioanalytical data with reduced or eliminated hematocrit bias.
The design features of these devices aid fluid draws from live hosts or tubes, high-throughput sample processing, and the ability to collect accurate microsamples with no precise lab equipment and limited training.
One excellent example under this category would be that of Mitra’s (RUO) Microsampler that combines the best of microsampling, wet sampling, and dried blood spotting into one, advanced collection device that is extraordinarily easy to use. Massive time and cost savings can be achieved by using this device.
“We can now sit at home and do a sample using the device, send it off, and get an accurate result without having to leave the comfort of our own home – It’s a lot less stressful, plus we don’t need to take a whole day out just to go for a blood test or clinic visit, which makes school attendance better.” – Caroline Knapp, mother of a young kidney transplant patient.
3) Continuous Glucose Monitoring Devices
Continuous Glucose Monitoring is another upcoming technology wherein devices take glucose measurements at regular intervals throughout the complete span of a day, and render the readings into dynamic data, generating glucose direction and its rate of change.
Having this clear understanding helps CGM users proactively manage glucose lows and highs. It also additionally gives added insight into impacts that exercise, meals, and illness may have on an individual’s glucose levels.
CGM can greatly contribute to better remote management of diabetes by helping to lower the conjecture that comes with making treatment decisions solely the basis of a number achieved from a blood glucose meter reading.
DexCom™ happens to be the very first company to establish continuous glucose sensing technologies. The company’s latest CGM device, Dexcom G6, abolishes the need to make finger pricks for glucose testing. Patients can now keep track of their blood sugar levels throughout the day using a sensor that is inserted under the skin.
A more progressive version of the device is in the works at the moment. The San Diego-based company has joined hands with Apple to connect the Apple Watch with its CGM sensor. DexCom’s upgraded device is expected to set the market ablaze in 2020.
Related: 4 Ways Telemedicine Is Streamlining Cardiac Care
4) Affordable Surgical Robots
Robotic surgical equipment has been available in the healthcare market since the past decade to help surgeons work with utmost accuracy in tight spots. However, this equipment has generally been too high-priced to be used in most operations.
Robots could soon play a more eminent role in the operating room as healthcare companies develop automated ones with steady hands that help surgeons with non-surgical needs, such as holding cameras, lights and telescopes in the right place during surgeries.
Surgical robots are also designed to carry out other compound procedures human surgeons often find challenging. The in-demand robotics’ high-ended price has been one of the biggest barriers faced by health organizations.
Hence, several companies are developing economical surgical robots. Riverfield™, a Japanese startup plans to launch a low-priced surgical robot in 2020. The company has received funding from Toray Engineering to increase its capital base and help develop a user-friendly surgical bot.
5) Remote Heart Monitoring Devices
Artificial intelligence (AI) has caused many industries to propel, including healthcare. In 2020, it is anticipated to augment computer vision. This technology will help devices make precise diagnoses much faster than us humans.
In 2019, Silicon Valley-based digital health company Eko announced Eko Home, a new service that enables precise remote monitoring of cardiac function using a patient’s heart sounds and electrocardiogram (ECG).
Eko Home can be used to design drug-data combinations to demonstrate real-world efficacy for pharma trials, while enabling clinicians to gather high-quality data while outside the clinical environment at the same time.
The future of drug trials includes continuous monitoring and better data, according to a recent Harvard Business Review report. Per the publication, digital technologies “can revolutionize the antiquated process of developing new drug therapies and can vastly improve how we collect, measure and assess health data so that we can offer new treatments to patients without wasting valuable time and limited resources.”
This is exactly what remote heart monitoring devices offer to researchers, providing precise monitoring for home cardiac patients as well as other biometric data.
As of now, Eko Home is surely one device to have on your radar.
It is going to be rather interesting to see how remote patient monitoring devices go down from becoming a recent addition in the healthcare realm to a revolutionary trend that transforms the industry in the years to follow.